{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:18:19Z","timestamp":1789492699325,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To investigate the relationship between the spatial arrangement of pachyvessels and polypoidal choroidal vasculopathy (PCV) lesions in relation to recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included 58 eyes of 58 patients with treatment-naive PCV who were followed for at least 1 year after receiving anti\u2013vascular endothelial growth factor injections, with or without photodynamic therapy. Using en face optical coherence tomography, the eyes were categorized into 2 groups based on the presence or absence of transmacular pachyvessels passing beneath PCV lesions (polypoidal lesions or branching neovascular networks). The primary outcome was the recurrence rate of PCV within 1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 58 eyes, 35 (60.3%) had pachyvessels located beneath PCV lesions. The 1-year recurrence rate was significantly higher in eyes with pachyvessels than without (71.4% vs. 39.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017). Univariable logistic regression analysis identified the presence of pachyvessels beneath lesions as a significant predictor (odds ratio, 3.89; 95% confidence interval, 1.28\u201311.84;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017). This remained the only significant predictor of recurrence within 1 year on multivariable logistic regression (odds ratio, 3.84; 95% confidence interval, 1.22\u201312.09;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The presence of transmacular pachyvessels may serve as a novel biomarker to predict prognosis and guide individualized treatment strategies for patients with PCV. These findings suggest that the anatomical relationship between pachyvessels and PCV lesions could be a critical factor in treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004758","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T21:00:10Z","timestamp":1767214810000},"page":"927-933","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["TRANSMACULAR PACHYVESSELS BENEATH POLYPOIDAL CHOROIDAL VASCULOPATHY LESIONS PREDICT LATER RECURRENCE"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5991-3846","authenticated-orcid":false,"given":"Hisashi","family":"Fukuyama","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"1","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"32","author":"Yannuzzi","year":"2012","journal-title":"Retina"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/archopht.117.11.1503","article-title":"Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration","volume":"117","author":"Yannuzzi","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IAE.0b013e318188c839","article-title":"A classification system for polypoidal choroidal vasculopathy","volume":"29","author":"Cackett","year":"2009","journal-title":"Retina"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging Society PCV workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archopht.117.8.1035","article-title":"Idiopathic polypoidal choroidal vasculopathy in Japanese patients","volume":"117","author":"Uyama","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41598-023-31649-x","article-title":"Clinical variations of polypoidal choroidal vasculopathy: a cohort study from Japan and the USA","volume":"13","author":"Fukuyama","year":"2023","journal-title":"Sci Rep"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye (Lond)"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.05.051","article-title":"Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability","volume":"142","author":"Sasahara","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","article-title":"Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration","volume":"118","author":"Chung","year":"2011","journal-title":"Ophthalmology"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid disease: review and update","volume":"39","author":"Cheung","year":"2025","journal-title":"Eye (Lond)"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s00417-022-05687-6","article-title":"A new insight into pachychoroid diseases: remodeling of choroidal vasculature","volume":"260","author":"Kishi","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"16274","DOI":"10.1038\/s41598-021-95904-9","article-title":"Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci Rep"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"13867","DOI":"10.1038\/s41598-021-93476-2","article-title":"Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/IAE.0000000000003395","article-title":"Association of flow signals within polyps on optical coherence tomography angiography with treatment RESPONSES after COMBINATION therapy for polypoidal choroidal vasculopathy","volume":"42","author":"Fukuyama","year":"2022","journal-title":"Retina"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1038\/s41598-020-66858-1","article-title":"Quantitative analyses of diameter and running pattern of choroidal vessels in central serous chorioretinopathy by en face images","volume":"10","author":"Shiihara","year":"2020","journal-title":"Sci Rep"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajo.2013.03.041","article-title":"Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy","volume":"156","author":"Maruko","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"2393273","DOI":"10.1080\/07853890.2024.2393273","article-title":"Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter study","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41598-022-06742-2","article-title":"Novel volumetric imaging biomarkers for assessing disease activity in eyes with PCV","volume":"12","author":"Vyas","year":"2022","journal-title":"Sci Rep"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/IAE.0000000000001758","article-title":"Choroidal vascular hyperpermeability as a predictor OF treatment response for polypoidal choroidal vasculopathy","volume":"38","author":"Yanagi","year":"2018","journal-title":"Retina"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-020-04924-0","article-title":"Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy","volume":"259","author":"Choi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2016.12.008","article-title":"Quantitative changes in pigment epithelial detachment area and volume predict retreatment in polypoidal choroidal vasculopathy","volume":"177","author":"Chan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00417-015-3241-6","article-title":"Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy","volume":"254","author":"Kang","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/ph17060687","article-title":"Association of polyp regression after loading phase with 12-Month outcomes of eyes with polypoidal choroidal vasculopathy","volume":"17","author":"Kimura","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41598-024-52448-y","article-title":"Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept","volume":"14","author":"Sayanagi","year":"2024","journal-title":"Sci Rep"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ophtha.2022.09.013","article-title":"Progression of polypoidal lesions associated with exudative recurrence in polypoidal choroidal vasculopathy","volume":"130","author":"Bo","year":"2023","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:38Z","timestamp":1789491638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004758","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}